AKOSUA ABANKWAH: Open Payments
NPI 1619281748 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,247 in 43 payments from 5 companies in 2025. Trend: 2023 $55 · 2024 $280 · 2025 $1,247
Food & beverage: $1,247
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 18 | $586 |
| Gilead Sciences, Inc. | 11 | $224 |
| E.R. Squibb & Sons, L.L.C. | 3 | $194 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $140 |
| Novo Nordisk Inc | 1 | $103 |
Products named: DOVATO, APRETUDE, CAMZYOS, CABENUVA, RELISTOR, Ozempic, ELIQUIS, Biktarvy.
Industry payments across NY — which companies pay providers there.
